Immunological activities of RU-41740, a glycoproteic extract from Klebsiella pneumoniae. I.--Activation of murine B cells and induction of interleukin-1 production by macrophages.

PubWeight™: 0.76‹?›

🔗 View Article (PMID 6385817)

Published in Ann Immunol (Paris) on November 19, 1984

Authors

M Guenounou, F Vacheron, R Zalisz, P Smets, J Agneray

Articles by these authors

European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci (1996) 6.12

Use of an intramedullary hip-screw compared with a compression hip-screw with a plate for intertrochanteric femoral fractures. A prospective, randomized study of one hundred patients. J Bone Joint Surg Am (1998) 2.83

A 500-kiloton airburst over Chelyabinsk and an enhanced hazard from small impactors. Nature (2013) 1.61

European stroke prevention study: effectiveness of antiplatelet therapy in diabetic patients in secondary prevention of stroke. Stroke (1992) 1.59

Expression of IL-17 in human memory CD45RO+ T lymphocytes and its regulation by protein kinase A pathway. Cytokine (1999) 1.45

Postoperative radiation therapy in lung caner: a controlled trial after resection of curative design. Int J Radiat Oncol Biol Phys (1980) 1.38

Selective up-regulation of chemokine IL-8 expression in cystic fibrosis bronchial gland cells in vivo and in vitro. Am J Pathol (1998) 1.31

Asymptomatic autoimmune thyroiditis and coronary heart-disease. Cross-sectional and prospective studies. Lancet (1977) 1.28

Production of interleukin 1 and tumour necrosis factor activities in bronchoalveolar washings following infection of mice by influenza virus. J Gen Virol (1990) 1.28

Pyrimethamine-sulfadoxine treatment of congenital toxoplasmosis: follow-up of 78 cases between 1980 and 1997. Reims Toxoplasmosis Group. Scand J Infect Dis (1998) 1.19

Implication of interleukin-4 in wound healing. Lab Invest (2000) 1.15

Serum ferritin and isoferritins are tools for diagnosis of active adult Still's disease. J Rheumatol (1994) 1.14

Regulation of IL-17, IFN-gamma and IL-10 in human CD8(+) T cells by cyclic AMP-dependent signal transduction pathway. Cytokine (1998) 1.12

Profound immunosuppression across the spectrum of opportunistic disease among hospitalized HIV-infected adults in Abidjan, Côte d'Ivoire. AIDS (1997) 1.11

Structure of the O-specific polysaccharide chain of Klebsiella pneumoniae O1K2 (NCTC 5055) lipopolysaccharide. A complementary elucidation. Carbohydr Res (1992) 1.10

Evaluation of computer-ECG programs. The strange case of the Golden standard. Comput Biomed Res (1979) 1.07

Y-chromosome-specific haplotype diversity in Ashkenazic and Sephardic Jews. Hum Biol (1993) 1.05

Impairment of lymphocyte proliferative responses and interleukin-2 production in susceptible (C57BL/6) mice infected with Salmonella typhimurium. Immunology (1986) 1.05

Structure of the O-specific polysaccharide chain from Klebsiella pneumoniae O1K2 (NCTC 5055) lipopolysaccharide. Carbohydr Res (1991) 1.03

Involvement of tumor necrosis factor alpha in intracellular multiplication of Legionella pneumophila in human monocytes. Infect Immun (1993) 1.03

Differential regulation of TNF alpha, IL-1 beta, IL-6, IL-8, TNF beta, and IL-10 by pentoxifylline. Int J Immunopharmacol (1996) 1.02

Differential regulation of IFN-gamma, IL-10 and inducible nitric oxide synthase in human T cells by cyclic AMP-dependent signal transduction pathway. Immunology (1997) 1.02

Alveolar type II epithelial cells produce interleukin-6 in vitro and in vivo. Regulation by alveolar macrophage secretory products. J Clin Invest (1994) 1.02

Chemical composition and biological activities of a phenol-water extract from Haemophilus influenzae type a. Infect Immun (1979) 1.00

Plasma levels of tumor necrosis factor-alpha (TNF-alpha) are essentially dependent on visceral fat amount in type 2 diabetic patients. Diabetes Metab (2000) 1.00

Induction of interleukin 1 secretion by adjuvant-active peptidoglycans. Infect Immun (1983) 0.99

[Enterobacter cloacae and E. aerogenes septicemia: emergence of resistant variants (derepressed cephalosporinase) during treatment with third-generation cephalosporins]. Presse Med (1985) 0.98

Lung concentrations of telithromycin after oral dosing. J Antimicrob Chemother (2001) 0.96

Effects of obstructive sleep apneas on transcutaneous oxygen pressure in control infants, siblings of sudden infant death syndrome victims, and near miss infants: comparison with the effects of central sleep apneas. Pediatrics (1982) 0.96

Pharmacokinetics and comparative effects of telithromycin (HMR 3647) and clarithromycin on the oropharyngeal and intestinal microflora. J Antimicrob Chemother (2000) 0.96

Prevalence of tri- and tetraantennary glycans of human alpha 1-acid glycoprotein in release of macrophage inhibitor of interleukin-1 activity. Inflammation (1990) 0.95

Murine monoclonal antibodies to Klebsiella pneumoniae protect against lethal endotoxemia and experimental infection with capsulated K. pneumoniae. Infect Immun (1990) 0.93

Dysregulation of IL-2 and IL-8 production in circulating T lymphocytes from young cystic fibrosis patients. Clin Exp Immunol (2004) 0.93

Activation of the cellular mitogen-activated protein kinase pathways ERK, P38 and JNK during Toxoplasma gondii invasion. Parasite (2003) 0.93

Tiapride versus placebo: a double-blind comparative study in the management of Huntington's chorea. Curr Med Res Opin (1984) 0.92

Pulmonary abscess due to a rifampin and fluoroquinolone resistant Rhodococcus equi strain in a HIV infected patient. Eur J Clin Microbiol Infect Dis (1992) 0.91

Protective effects of murine monoclonal antibodies in experimental septicemia: E. coli antibodies protect against different serotypes of E. coli. J Infect Dis (1989) 0.91

Measurement of serum alpha 1-acid glycoprotein and alpha 1-antitrypsin desialylation in liver disease. Hepatology (1983) 0.91

Comparative study of biological activities and mitogenic effect of extracts from Haemophilus influenzae type a. Med Microbiol Immunol (1980) 0.91

Effects of food ingestion on the cell proliferation kinetics in the canine fundic mucosa. Gastroenterology (1971) 0.90

Differential spontaneous expression of mRNA for IL-4, IL-10, IL-13, IL-2 and interferon-gamma (IFN-gamma) in peripheral blood mononuclear cells (PBMC) from atopic patients. Clin Exp Immunol (1996) 0.90

Effect of hydroxyapatite sintering temperature on intracellular ionic concentrations of monocytes: a TEM-cryo-X-ray microanalysis study. J Biomed Mater Res (2001) 0.88

Interferon-gamma signal transduction during parasite infection: modulation of MAP kinases in the infection of human monocyte cells (THP1) by Toxoplasma gondii. Parasite Immunol (1998) 0.87

Inhibition of human TNF alpha and LT in cell-free extracts and in cell culture by antisense oligonucleotides. Biochim Biophys Acta (1996) 0.87

Determination of erythrocyte surface sialic acid residues by a new colorimetric method. Anal Biochem (1979) 0.87

Involvement of interferon-gamma and tumor necrosis factor-alpha in host defense against Rhodococcus equi. J Infect Dis (1993) 0.86

Origins of Falasha Jews studied by haplotypes of the Y chromosome. Hum Biol (1999) 0.86

Cell proliferation in the mucosa of Heidenhain pouches after feeding in dogs. Am J Dig Dis (1972) 0.86

Tissue kinetics of telithromycin, the first ketolide antibacterial. J Antimicrob Chemother (2004) 0.85

Role of interferon-gamma against invasion by Toxoplasma gondii in a human monocytic cell line (THP1): involvement of the parasite's secretory phospholipase A2. Cell Immunol (1996) 0.85

Escherichia coli pyometra induces transient glomerular and tubular dysfunction in dogs. J Vet Intern Med (2010) 0.85

Preparation of a nontoxic and immunogenic polysaccharide fraction from a Haemophilus influenzae phenol-water extract. Infect Immun (1980) 0.84

Pharmacokinetics of the ketolide telithromycin after single and repeated doses in patients with hepatic impairment. Int J Antimicrob Agents (2003) 0.84

Human alpha 1-acid glycoprotein-exposed macrophages release interleukin 1 inhibitory activity. Biochem Biophys Res Commun (1987) 0.84

Suppression of primary antibody response in genetically susceptible mice infected with Salmonella typhimurium: restoration by catalase. Res Immunol (1989) 0.84

Characteristics of a lipid preparation (lipid A) from Haemophilus influenzae type a lipopolysaccharide. Infect Immun (1981) 0.84

Evaluation of kidney injury in dogs with pyometra based on proteinuria, renal histomorphology, and urinary biomarkers. J Vet Intern Med (2011) 0.84

Effect of thyroxine supplementation on glomerular filtration rate in hypothyroid dogs. J Vet Intern Med (2009) 0.84

Regulatory effects of pentoxifylline on T-helper cell-derived cytokine production in human blood cells. J Cardiovasc Pharmacol (1995) 0.84

Study of adjuvant and mitogenic activities of bacterial peptidoglycans with different structures. Ann Immunol (Paris) (1983) 0.83

Toxicity and activity of purified trichosanthin. AIDS (1991) 0.83

Inhibition of production of tumor necrosis factor by monoclonal antibodies to lipopolysaccharides. J Infect Dis (1992) 0.83

Effect of streptozotocin diabetes on sialic acid content and glycoprotein binding of isolated hepatocytes. Horm Metab Res (1980) 0.83

[Detection of extended broad-spectrum beta-lactamases with the ATB MIC system]. Pathol Biol (Paris) (1991) 0.83

Assessment of renal dysfunction using urinary markers in canine babesiosis caused by Babesia rossi. Vet Parasitol (2012) 0.82

Sodium periodate-induced suppressor T cells of the human in vitro antibody response. Cell Immunol (1980) 0.82

Interaction of virulent and non-virulent Rhodococcus equi human isolates with phagocytes, fibroblast- and epithelial-derived cells. FEMS Immunol Med Microbiol (1994) 0.82

High-dose alizapride versus high-dose domperidone: a double-blind comparative study in the management of cis-platinum-induced emesis. Curr Med Res Opin (1985) 0.81

Fate of enterally administered ornithine in healthy animals: interactions with alpha-ketoglutarate. Nutrition (1992) 0.81

Alterations in relative proportions of microheterogenous forms of human alpha 1-acid glycoprotein in liver disease. J Hepatol (1986) 0.81

Retinol-binding protein in serum and urine of hyperthyroid cats before and after treatment with radioiodine. J Vet Intern Med (2009) 0.81

The European Stroke Prevention Study: results according to sex. Neurology (1991) 0.81

Antiplatelet treatment does not reduce the severity of subsequent stroke. European Stroke Prevention Study 2 Working Group. Neurology (1999) 0.80

Second European Stroke Prevention Study: antiplatelet therapy is effective regardless of age. ESPS2 Working Group. Acta Neurol Scand (1999) 0.80

Comparative study of growth hormone response to hypoglycemia in normal subjects and in patients with primary myxedema or hyperthyroidism before and after treatment. J Clin Endocrinol Metab (1973) 0.80

Alterations in the carbohydrate moiety of alpha-1-acid glycoprotein purified from human cirrhotic ascitic fluid. Biochim Biophys Acta (1987) 0.80

Regulation of tumor necrosis factor alpha and its specific receptors during Toxoplasma gondii infection in human monocytic cells. Parasitol Res (2002) 0.80

Antisense oligonucleotides to interleukin-4 regulate IgE and IgG2a production by spleen cells from Nippostrongylus brasiliensis-infected rats. Eur J Immunol (1993) 0.80

Tumour necrosis factor, IL-1 and IL-6 in bronchoalveolar washings and their in vitro production during Nippostrongylus brasiliensis infection. Clin Exp Immunol (1992) 0.80

Insulin-like growth factor I/somatomedin C action on 2-deoxyglucose and alpha-amino isobutyrate uptake in chick embryo fibroblasts. Biochimie (1986) 0.80

Direct evidence for sialic acid oxidation in periodate-induced lymphocyte proliferation. Biochem Biophys Res Commun (1978) 0.79

Cystatin C: a new renal marker and its potential use in small animal medicine. J Vet Intern Med (2014) 0.79

Urinary biomarkers for acute kidney injury in dogs. J Vet Intern Med (2013) 0.79

Inhibition by sodium periodate of the in vitro antibody response of mouse spleen cells and its reversal by borohydride or aldehyde blocking reagents. Cell Immunol (1981) 0.79